Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Bone-marrow and epidermal stem cells help heal wounds differently, with bone-marrow cells aiding in blood vessel formation and epidermal cells in hair growth.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

Minoxidil effectively treats hair loss, with better results in women.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Stem cell treatments may improve burn wound healing.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.